Operating Lease, Right-of-Use Asset of Aldeyra Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aldeyra Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Aldeyra Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $275,861, a 3.3% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aldeyra Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $275,861 +$8,906 +3.3% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $340,977 +$11,009 +3.3% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $404,660 +$13,065 +3.3% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $466,942 +$15,075 +3.3% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $266,955 -$243,859 -48% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $329,968 +$265,509 +412% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $391,595 +$264,147 +207% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $451,867 +$262,834 +139% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $510,814 +$261,549 +105% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $64,459 -$117,484 -65% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $127,448 -$112,425 -47% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $189,033 -$107,471 -36% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $249,265 -$102,598 -29% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $181,943 -$224,071 -55% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $239,873 +$121,472 +103% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $296,504 +$120,885 +69% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $351,863 +$118,553 +51% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $406,014 +$353,819 +678% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 $118,401 +$15,327 +15% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $175,619 +$22,953 +15% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $233,310 +$32,303 +16% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $52,195 -$195,970 -79% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $103,074 -$191,099 -65% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $152,666 -$225,254 -60% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $201,007 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $248,165 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $294,173 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $377,920 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.